Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,871 | 41,506 | 42,316 | 33,175 | 34,884 |
| Marketable Securities | 15,279 | 15,114 | 27,560 | 45,344 | 53,662 |
| Receivables | 6,858 | 4,960 | 3,458 | 23 | 23 |
| TOTAL | $44,868 | $64,647 | $74,411 | $80,626 | $92,171 |
| Non-Current Assets | |||||
| PPE Net | 2,589 | 2,872 | 2,854 | 3,053 | 3,401 |
| Other Non-Current Assets | 8,102 | 9,069 | 10,013 | 10,939 | 11,846 |
| TOTAL | $10,691 | $11,941 | $12,867 | $13,992 | $15,247 |
| Total Assets | $55,559 | $76,588 | $87,278 | $94,618 | $107,418 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 6,667 | 6,667 | 6,667 | 5,000 |
| Accounts payable and accrued liabilities | 1,110 | 1,331 | 936 | 1,408 | 1,051 |
| Accrued Expenses | 5,835 | 3,506 | 6,021 | 5,947 | 6,505 |
| TOTAL | $25,247 | $28,989 | $30,994 | $30,555 | $33,320 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 10,413 | 12,021 | 13,621 | 15,218 |
| Deferred Revenues | 13,779 | 12,987 | 12,885 | 12,071 | 16,323 |
| Other Non-Current Liabilities | 2,865 | 3,892 | 5,121 | 6,032 | 7,074 |
| TOTAL | $2,865 | $14,305 | $17,142 | $19,653 | $22,292 |
| Total Liabilities | $28,112 | $43,294 | $48,136 | $50,208 | $55,612 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,514 | 2,501 | 2,497 | 2,496 | 2,492 |
| Common Shares | 3 | 32 | 3 | 32 | 32 |
| Retained earnings | -271,684 | -264,178 | -256,800 | -250,115 | -241,444 |
| Other shareholders' equity | -177 | -273 | -429 | -636 | -556 |
| TOTAL | $27,447 | $33,294 | $39,142 | $44,410 | $51,806 |
| Total Liabilities And Equity | $55,559 | $76,588 | $87,278 | $94,618 | $107,418 |